In a world of constant connectivity and mounting pressures, generalized anxiety disorder (GAD) has emerged as a significant mental health challenge affecting millions. Recent studies show that anxiety ...

Dr Bradley Gaynes discusses how cultural context can shape anxiety symptoms, diagnosis, and treatment engagement among ...

Anxiety disorders are among the most prevalent mental health conditions globally, affecting millions of individuals across various age groups. Characterized by persistent and excessive worry, fear, or ...

Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new ...

Anxiety disorders are a group of disorders that share symptoms like excessive fear and heightened stress (American Psychological Association [APA], 2022). It is important to note that fear and anxiety ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

Cognitive behavioral therapy (CBT) should be considered first-line treatment for generalized anxiety disorder in adults, according to a systematic review and network meta-analysis of 66 randomized ...

Mental disorders like depression and anxiety are characterized by a variety of different symptoms, and individuals receiving the same diagnosis may experience different combinations of those symptoms.

Anxiety is a significant feature of mental health conditions besides generalized anxiety disorder, marked by a state of persistent worry and apprehension. Perhaps most prominently, anxiety is a ...

Accessibility to cognitive behavioral therapy (CBT) is a barrier to use due to a lack of trained providers and the burden of in-person treatment. A randomized trial showed that a smartphone-delivered ...

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.